Medicinal products containing efanesoctocog alfa
Original notice title
Czechia – Pharmaceutical products – Léčivé přípravky s účinnou látkou EFANESOKTOKOG ALFA
Opportunity Score
Why this score?
Opportunity
0 / 100
Complexity
0 / 100
Risk factors
Submission deadline in 13 days
Deep Portfolio Analysis
Uses:
- Description
- Industries & Services
- Capabilities
- Market & Experience
- Certifications
Tender facts
- Contracting authority
- Fakultní nemocnice Brno
- Country
- Czech Republic
- CPV
- 33600000 - Pharmaceutical products
- Deadline
- Dec 03, 2026
AI tender analysis
Tenderwize prepares an AI analysis of this tender based on the TED notice and procurement documents: scope of work, key requirements, eligibility criteria, risks and questions for the buyer. The analysis is generated when the tender is opened.
Award Criteria
Lot 1
Buyer
Location
Brno, CZE
Website
Buyer profile
Identifier
65269705
Activity
Health
Lots (1)
LOT-0001
Léčivé přípravky s účinnou látkou EFANESOKTOKOG ALFA
Předmětem zadávacího řízení je uzavření rámcové kupní smlouvy na dodávky léčivých přípravků dle potřeb zadavatele.
Location
Duration
Category
Award Criteria
Award details
Ekonomická výhodnost nabídky
Procurement Details
- Publication date
- 02 Nov 2026
- Languages
- Czech
Reference metadata
- Legal basis
- 32014L0024
Reference IDs
- Tender ID
- 761946-2026
Documents (1)
Similar tenders
Germany – Pharmaceutical products – Open-House-Biologika-Rabattverträge 2026-09 - Etanercept
Germany – Pharmaceutical products – Arzneimittelrabattverträge gem. § 130a Abs. 8 SGB V im Rahmen von Open-House-Verfahren
Czechia – Pharmaceutical products – Léčivý přípravek ATC skupiny L04AC21 s účinnou látkou BIMEKIZUMAB
Norway – Medical equipments, pharmaceuticals and personal care products – Framework agreement for medicines and multi-dose.
Germany – Pharmaceutical products – Open House Biologika Rabattverträge 2026 - 15 Ranibizumab
Germany – Pharmaceutical products – Open House Biologika Rabattverträge 2026-24 - Aflibercept (ATC: S01LA05; Wirkstärke: 40 mg/ml)
Opportunity Score
Why this score?
Opportunity
0 / 100
Complexity
0 / 100
Risk factors
Submission deadline in 13 days
Deep Portfolio Analysis
Uses:
- Description
- Industries & Services
- Capabilities
- Market & Experience
- Certifications